These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7075111)

  • 1. Phencyclidine disposition after intravenous and oral doses.
    Cook CE; Brine DR; Jeffcoat AR; Hill JM; Wall ME; Perez-Reyes M; Di Guiseppi SR
    Clin Pharmacol Ther; 1982 May; 31(5):625-34. PubMed ID: 7075111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phencyclidine disposition in humans after small doses of radiolabeled drug.
    Cook CE; Perez-Reyes M; Jeffcoat AR; Brine DR
    Fed Proc; 1983 Jun; 42(9):2566-9. PubMed ID: 6852275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phencyclidine (PCP) disposition kinetics in dogs as a function of dose and route of administration.
    Woodworth JR; Owens SM; Mayersohn M
    J Pharmacol Exp Ther; 1985 Sep; 234(3):654-61. PubMed ID: 4032285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phencyclidine and phenylcyclohexene disposition after smoking phencyclidine.
    Cook CE; Brine DR; Quin GD; Perez-Reyes M; Di Guiseppi SR
    Clin Pharmacol Ther; 1982 May; 31(5):635-41. PubMed ID: 7075112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition kinetics of the monohydroxy metabolites of phencyclidine in the dog.
    Woodworth JR; Mayersohn M; Owens SM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):900-4. PubMed ID: 3746667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine pH and phencyclidine excretion.
    Perez-Reyes M; Di Guiseppi S; Brine DR; Smith H; Cook CE
    Clin Pharmacol Ther; 1982 Nov; 32(5):635-41. PubMed ID: 7128004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term disposition of phencyclidine in mice.
    Martin BR
    Drug Metab Dispos; 1982; 10(2):189-93. PubMed ID: 6124408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition, bioavailability, and serum protein binding of pentachlorophenol in the B6C3F1 mouse.
    Reigner BG; Rigod JF; Tozer TN
    Pharm Res; 1992 Aug; 9(8):1053-7. PubMed ID: 1409377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phencyclidine-specific Fab fragments alter phencyclidine disposition in dogs.
    Owens SM; Mayersohn M
    Drug Metab Dispos; 1986; 14(1):52-8. PubMed ID: 2868866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Aminopyridine kinetics.
    Uges DR; Sohn YJ; Greijdanus B; Scaf AH; Agoston S
    Clin Pharmacol Ther; 1982 May; 31(5):587-93. PubMed ID: 7075108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous and oral 1,2-O-isopropylidene-3-O-3'-(N',N'-dimethylamino-n-propyl)-D-glucofuranose hydrochloride in the dog as a function of dose and characterization of metabolites.
    Garrett ER; Van Peer A
    J Pharm Sci; 1983 Sep; 72(9):1045-57. PubMed ID: 6631692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
    Colletti AE; Krieter PA
    Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of phencyclidine and its hydroxylated metabolites into hair.
    Sakamoto T; Tanaka A; Nakahara Y
    Life Sci; 1998; 62(6):561-70. PubMed ID: 9464469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of metformin after intravenous and oral administration to man.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Eur J Clin Pharmacol; 1979 Sep; 16(3):195-202. PubMed ID: 499320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of oral [14C]cefcanel daloxate hydrochloride in healthy male subjects.
    Edwall B; Arvidsson A; Lake-Bakaar D; Lanbeck-Vallén K; Yisak W
    Drug Metab Dispos; 1993; 21(1):171-7. PubMed ID: 8095213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.
    Jezequel SG; Uden S; Wastall P
    Xenobiotica; 1996 Sep; 26(9):963-75. PubMed ID: 8893043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
    Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.